Management of Bloody Diarrhea with Fever
For adults with bloody diarrhea and fever, empiric antibiotic therapy with either a fluoroquinolone (ciprofloxacin) or azithromycin should be initiated immediately, with the choice based on local resistance patterns and travel history. 1
Empiric Antibiotic Therapy
Adults
- First-line options: Ciprofloxacin (fluoroquinolone) OR azithromycin 1
- Selection criteria: Base choice on:
- Local antimicrobial susceptibility patterns
- Recent international travel history
- Known regional resistance (e.g., increasing fluoroquinolone resistance in Campylobacter) 2
Children
- Infants <3 months: Third-generation cephalosporin 1
- Older children with neurologic involvement: Third-generation cephalosporin 1
- Other children: Azithromycin (based on local patterns and travel history) 1
Special Populations Requiring Empiric Treatment
The 2017 IDSA guidelines specify empiric antibiotics are indicated for: 1
- Infants <3 months with suspected bacterial etiology
- Ill patients with documented fever, abdominal pain, bloody diarrhea, and bacillary dysentery (frequent scant bloody stools, fever, cramps, tenesmus) presumed to be Shigella
- Recent international travelers with temperature ≥38.5°C and/or signs of sepsis
- Immunocompromised patients with severe illness and bloody diarrhea 1
Critical Caveat: STEC Infections
Avoid antibiotics if Shiga toxin-producing E. coli (STEC) O157 or other Shiga toxin 2-producing strains are suspected or confirmed (strong recommendation). 1 This is because antibiotics can increase the risk of hemolytic uremic syndrome. If only low-grade or no fever is present with acute dysentery, suspect STEC and obtain specific testing before initiating antibiotics. 3
Supportive Care: Fluid Replacement
Mild to Moderate Dehydration
- First-line: Reduced osmolarity oral rehydration solution (ORS) 1
- Continue ORS until clinical dehydration is corrected 1
- Nasogastric ORS may be used if patient cannot tolerate oral intake 1
Severe Dehydration
- Immediate treatment: Isotonic IV fluids (lactated Ringer's or normal saline) 1
- Indications for IV fluids:
- Severe dehydration
- Shock
- Altered mental status
- Failure of ORS therapy
- Ileus 1
- Continue IV rehydration until pulse, perfusion, and mental status normalize 1
- Once stabilized, transition to ORS for remaining deficit replacement 1
Maintenance After Rehydration
- Replace ongoing stool losses with ORS until diarrhea resolves 1
- Resume age-appropriate diet immediately after rehydration 1
- Continue breastfeeding in infants throughout illness 1
Additional Management Considerations
Antimotility Agents
Avoid loperamide and other antimotility drugs in patients with bloody diarrhea and fever (strong recommendation). 1 These agents should not be used when toxic megacolon may result from inflammatory diarrhea or in any patient with fever and bloody stools.
Diagnostic Testing
- Obtain blood, stool, and urine cultures before initiating antibiotics if sepsis is suspected 1
- Modify or discontinue antibiotics once a specific pathogen is identified 1
- If STEC is suspected, specifically test for E. coli O157:H7 and Shiga toxin directly in stool 3
When to Suspect Enteric Fever
If clinical features of sepsis are present, consider enteric fever and initiate broad-spectrum antimicrobial therapy after obtaining cultures. 1 Narrow therapy once susceptibility results are available.
Key Clinical Algorithm
- Assess severity: Check for fever, signs of sepsis, dehydration status
- Initiate rehydration: ORS for mild-moderate; IV fluids for severe dehydration
- Consider STEC: If minimal/no fever with dysentery, test before treating
- Start empiric antibiotics if:
- Documented fever with bloody diarrhea
- Recent international travel with fever ≥38.5°C
- Immunocompromised with severe illness
- Infant <3 months
- Choose antibiotic: Fluoroquinolone vs azithromycin based on local resistance and travel history
- Avoid antimotility agents
- Obtain cultures and adjust therapy when results available
The evidence strongly supports this approach, with the 2017 IDSA guidelines providing the most comprehensive and authoritative recommendations for this clinical scenario. 1